In today's ACT Brief, we examine why black-box AI fails in clinical trials, how participant understanding drives engagement ...

In this Q&A, John Worden, chief commercial officer at Javara, discusses why clinical trial recruitment has remained stubbornly one-size-fits-all, how AI can identify patients at scale without ...

In this Q&A, Patrick Mizer, chief technology officer at Ledger Run, discusses how payment reliability has become a ...

Across both participant-centered research and broader industry data, a consistent theme emerges: engagement is not a request for novelty. It is a request for less friction. Participants are asking for ...

In today's ACT Brief, we examine value hidden in the RBQM financial model, why rare disease research leads on genuine patient ...

Beyond Compliance: NetraMark's Joseph Geraci, PhD, on Making AI-Driven Patient Subgroups Explainable ...

In this video interview, Sylviane de Viron of CluePoints and Abigail Dirks of Tufts CSDD discuss what the RBQM financial ...

Senior leaders reiterated that GCP expectations are geography-agnostic, and inadequate inspection access can render foreign ...

Agentic AI is arriving in clinical operations with genuine capability to absorb administrative work, but the organizations ...

In this video interview, Sylviane de Viron of CluePoints and Abigail Dirks of Tufts CSDD explain why time savings dominates ...

In this video interview, Sylviane de Viron of CluePoints and Abigail Dirks of Tufts CSDD explain how combining real-world ...

Static budgeting models and one-size-fits-all fair market value approaches create visibility gaps around inflation and true ...